Antonio Jose C. M.
- Country
- Spain
- Department
- Oncología Radioterápica
Research Overview
- Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial
- Evaluation of Darolutamide and Stereotactic Dose-Escalated Radiotherapy in High-Risk Localized Prostate Cancer: A Phase III Randomized Trial
- Comparison of Short- and Long-term Androgen Deprivation Therapy with Salvage Radiotherapy in Prostate Cancer Recurrence: A Phase III Randomized Trial
Data & Insights
Has run more than one trial at 21 of 170 partner sites.
Specializations
Prostate Cancer Management
This investigator specializes in treating various stages of prostate cancer, with particular emphasis on managing cases with biochemical recurrence and high-risk features.
- Biochemically Recurrent Disease
- High-Risk Localized Cancer
- Post-Surgical Recurrence
The investigator utilizes advanced diagnostic methods including PSMA PET/CT imaging for precise disease monitoring.
Therapeutic Approaches
Expertise in implementing comprehensive treatment strategies combining androgen deprivation therapy (ADT) with other therapeutic modalities.
- Combined Hormone Therapy
- Salvage Radiotherapy
- Stereotactic Radiation Treatment
Special focus on targeted radiation approaches including pelvic nodal radiotherapy for localized disease.
Disease Monitoring
Specialized in evaluating treatment outcomes through sophisticated monitoring of disease progression markers and survival metrics.
- PSA Level Monitoring
- Metastasis-Free Survival Assessment
- Advanced Imaging Surveillance
Utilizes next-generation imaging techniques for precise disease staging and treatment response evaluation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.